[1]
authors, N. 2022. UK Kidney Association Clinical Practice Guideline: Sodium-Glucose Co-transporter-2 (SGLT-2) Inhibition in Adults with Kidney Disease. KIDNEYS. 11, 1 (May 2022), 30–36. DOI:https://doi.org/10.22141/2307-1257.11.1.2022.356.